In the complex world of oncology, multiple myeloma (MM) stands as a formidable challenge, affecting thousands across Europe with its intricate disease mechanisms and diverse patient needs. As the second most common blood cancer after non-Hodgkin lymphoma, MM impacts around 46,000 new individuals
In the complex aftermath of the Supreme Court's 2022 Dobbs v. Jackson Women's Health Organization ruling, which dismantled nationwide abortion rights, a fierce struggle over reproductive healthcare has erupted across state lines in the United States. Republican state attorneys general (AGs) are
The European Medicines Agency (EMA) has recommended the approval of Moderna's LP.8.1-adapted COVID-19 vaccine to address the challenges posed by the SARS-CoV-2 variant LP.8.1. Following the guidance of EMA's Emergency Task Force, the formulation of Spikevax has been tailored to combat the current
In the ever-evolving landscape of cancer treatment, AstraZeneca’s Imfinzi represents a significant step forward in managing early-stage gastric cancer. Ivan Kairatov, a biopharmaceutical expert with a wealth of knowledge in biotechnology and innovation, shares insights into how this immunotherapy
For those acquainted with the world of reality television, Teddi Mellencamp is a familiar name; however, her battle with stage 4 cancer has taken center stage in recent months. Known for her openness and vulnerability, Mellencamp has kept the public updated about her health, particularly focusing
The cancer treatment market is witnessing monumental shifts as leading innovations pave a new path, notably in the fight against mantle cell lymphoma (MCL). With Imbruvica (ibrutinib) being sanctioned by the European Commission as a frontline treatment, a significant transformation in cancer
